Rocket Pharmaceuticals Ownership | Who Owns Rocket Pharmaceuticals?

Overview Forecast RevenueFinancials Chart

Rocket Pharmaceuticals Ownership Summary

Rocket Pharmaceuticals is owned by 62.98% institutional investors, 3.70% insiders, and 33.33% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 15.93% of RCKT shares. Vanguard Health Care Inv is the top mutual fund, with 7.11% of its assets in Rocket Pharmaceuticals shares.

RCKT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Rocket Pharmaceuticals	62.98%	3.70%	33.33%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rtw investments, lp	17.69M	15.93%	$57.66M
Maverick capital	8.47M	7.63%	$27.61M
Blackrock	6.19M	6.61%	$133.33M
Blackrock funding, inc. /de	7.11M	6.41%	$23.19M
Vanguard group	6.89M	6.21%	$22.47M
Janus henderson group	4.00M	4.25%	$50.34M
Bioimpact capital	3.90M	3.52%	$12.73M
Suvretta capital management	3.84M	3.46%	$12.53M
Morgan stanley	3.65M	3.29%	$11.89M
Monaco asset management sam	2.89M	2.61%	$9.43M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	150.71K	2.53%	$1.89M
Bioimpact capital	3.90M	2.08%	$12.73M
M28 capital management lp	385.68K	1.85%	$1.26M
Boxer capital	1.47M	1.66%	$31.56M
Lion point capital, lp	86.00K	1.59%	$280.36K
Newtyn management	2.50M	1.00%	$8.16M
Prosight management, lp	1.27M	0.96%	$4.13M
Rtw investments, lp	17.69M	0.71%	$57.66M
Cowen and company	1.10M	0.65%	$23.68M
Monaco asset management sam	2.89M	0.57%	$9.43M

Top Buyers

Holder	Shares	% Assets	Change
Monaco asset management sam	2.89M	0.57%	2.44M
Janus henderson group	4.00M	0.03%	2.11M
Jpmorgan chase	2.10M	0.00%	889.23K
Vanguard group	6.89M	0.00%	769.74K
Newtyn management	2.50M	1.00%	502.86K

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	-	-	-12.63M
Westfield capital management co lp	-	-	-4.82M
Point72 asset management	-	-	-1.57M
Pictet asset management sa	-	-	-1.32M
Avoro capital advisors	-	-	-1.20M

New Positions

Holder	Shares	% Assets	Change	Value
Nebula research & development	100.78K	0.02%	100.78K	$246.91K
Ballentine partners	88.57K	0.00%	88.57K	$288.74K
Lion point capital, lp	86.00K	1.59%	86.00K	$280.36K
Man group	62.58K	0.00%	62.58K	$204.00K
Atom investors lp	53.33K	0.01%	53.33K	$173.87K

Sold Out

Holder	Change
Allspring global investments	-20.00
Smartleaf asset management	-20.00
First horizon advisors	-24.00
Evermay wealth management	-25.00
Northwestern mutual wealth management	-38.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	152	-22.84%	69,915,346	-20.60%	62	1.00%	73	-38.66%	55	27.91%
Jun 30, 2025	204	-17.07%	94,897,210	-11.80%	85	0.89%	123	-23.13%	44	2.33%
Mar 31, 2025	246	5.58%	107,782,550	-1.70%	97	0.72%	160	4.58%	43	-6.52%
Dec 31, 2024	215	8.59%	85,361,633	-7.77%	90	0.94%	140	44.33%	43	-20.37%
Sep 30, 2024	198	7.03%	92,550,219	1.43%	98	1.04%	97	-2.02%	54	10.20%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	7.60M	7.11%	-
Vanguard Total Stock Mkt Idx Inv	2.71M	2.51%	-59.72K
RTW Biotech Opportunities Ord	2.40M	2.25%	-
Vanguard US Total Market Shares ETF	2.21M	2.08%	-245.50K
iShares Russell 2000 ETF	2.02M	1.87%	-
SPDR® S&P Biotech ETF	1.79M	1.66%	10.61K
Westfield Capital Mgt Co Sm-Cap Gr Eq	1.23M	1.16%	22.76K
Harbor Small Cap Growth Instl	1.23M	1.14%	-
Vanguard Small Cap Index	1.05M	0.97%	3.90K
US Small-Cap Growth II Equity Comp	993.80K	0.93%	-13.73K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 18, 2025	Schwartz Jonathan David	See Remarks	Sell	$7.59K
Nov 18, 2025	Shah Gaurav	CEO	Sell	$18.72K
Nov 18, 2025	Militello John	See Remarks	Sell	$3.24K
Nov 18, 2025	Wilson Martin	General Counsel	Sell	$4.91K
Oct 14, 2025	Militello John	See Remarks	Sell	$11.93K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	8
2025 Q3	1	10
2025 Q2	2	12
2025 Q1	-	6
2024 Q3	-	6

RCKT Ownership FAQ

Who Owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals shareholders are primarily institutional investors at 62.98%, followed by 3.70% insiders and 33.32% retail investors. The average institutional ownership in Rocket Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Rocket Pharmaceuticals exceeds.

Who owns the most shares of Rocket Pharmaceuticals?

Rocket Pharmaceuticals’s largest shareholders are Rtw investments, lp (17.69M shares, 15.93%), Maverick capital (8.47M shares, 7.63%), and Blackrock (6.19M shares, 6.61%). Together, they hold 30.17% of Rocket Pharmaceuticals’s total shares outstanding.

Does Blackrock own Rocket Pharmaceuticals?

Yes, BlackRock owns 6.61% of Rocket Pharmaceuticals, totaling 6.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 133.33M$. In the last quarter, BlackRock increased its holdings by 262.72K shares, a 4.43% change.

Who is Rocket Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Rocket Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.53% of its assets in 150.71K Rocket Pharmaceuticals shares, valued at 1.89M$.

Who is the top mutual fund holder of Rocket Pharmaceuticals shares?

Vanguard Health Care Inv is the top mutual fund holder of Rocket Pharmaceuticals shares, with 7.11% of its total shares outstanding invested in 7.6M Rocket Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools